FIELD: chemistry.
SUBSTANCE: invention relates to potassium 1-[(4-phenyl-2-pyrrolidone-1-yl)acetyl] taurate, to a low-toxic nootropic composition for the treatment and preventive treatment of central nervous system disorders, containing potassium 1-[(4-phenyl-2-pyrrolidone-1-yl)acetyl] taurate, potassium taurate and water, to a method for producing potassium 1-[(4-phenyl-2-pyrrolidone-1-yl)acetyl] taurate, the claimed composition and method for the treatment and preventive treatment of central nervous system disorders, involving administration of preventive or therapeutically effective amounts of the said composition.
EFFECT: improved effectiveness of the compound.
5 cl, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2018 |
|
RU2699669C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
| COMPOUNDS HAVING ANTI-ISCHEMIC, ANTIANGINAL, CYTOPROTECTIVE PROPERTIES, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF, A METHOD OF TREATING A NEURODEGENERATIVE DISEASE, A METHOD OF TREATING A PSYCHIC DISORDER | 2019 |
|
RU2741910C2 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE FOR TREATING AND PREVENTING OBESITY | 2019 |
|
RU2732245C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTION AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2524651C1 |
| PHARMACEUTICAL COMPOSITION ELICITING NOOTROPIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240783C1 |
